Cargando…

Olanzapine, risperidone and quetiapine: Do these atypical antipsychotics have a protective effect for SARS-CoV-2?

Detalles Bibliográficos
Autores principales: Prokopez, Cintia R., Farinola, Romina, Vallejos, Miguel, Lopredo, Lorena S., Sfriso, Luciano E., Chiapella, Luciana C., Arce, Claudio, Corral, Ricardo M., Cuesta, Manuel J., Alomo, Martín
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier B.V. 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8784573/
https://www.ncbi.nlm.nih.gov/pubmed/35123336
http://dx.doi.org/10.1016/j.schres.2022.01.035
_version_ 1784638769458053120
author Prokopez, Cintia R.
Farinola, Romina
Vallejos, Miguel
Lopredo, Lorena S.
Sfriso, Luciano E.
Chiapella, Luciana C.
Arce, Claudio
Corral, Ricardo M.
Cuesta, Manuel J.
Alomo, Martín
author_facet Prokopez, Cintia R.
Farinola, Romina
Vallejos, Miguel
Lopredo, Lorena S.
Sfriso, Luciano E.
Chiapella, Luciana C.
Arce, Claudio
Corral, Ricardo M.
Cuesta, Manuel J.
Alomo, Martín
author_sort Prokopez, Cintia R.
collection PubMed
description
format Online
Article
Text
id pubmed-8784573
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier B.V.
record_format MEDLINE/PubMed
spelling pubmed-87845732022-01-24 Olanzapine, risperidone and quetiapine: Do these atypical antipsychotics have a protective effect for SARS-CoV-2? Prokopez, Cintia R. Farinola, Romina Vallejos, Miguel Lopredo, Lorena S. Sfriso, Luciano E. Chiapella, Luciana C. Arce, Claudio Corral, Ricardo M. Cuesta, Manuel J. Alomo, Martín Schizophr Res Letter to the Editor Elsevier B.V. 2022-03 2022-01-24 /pmc/articles/PMC8784573/ /pubmed/35123336 http://dx.doi.org/10.1016/j.schres.2022.01.035 Text en © 2022 Elsevier B.V. All rights reserved. Since January 2020 Elsevier has created a COVID-19 resource centre with free information in English and Mandarin on the novel coronavirus COVID-19. The COVID-19 resource centre is hosted on Elsevier Connect, the company's public news and information website. Elsevier hereby grants permission to make all its COVID-19-related research that is available on the COVID-19 resource centre - including this research content - immediately available in PubMed Central and other publicly funded repositories, such as the WHO COVID database with rights for unrestricted research re-use and analyses in any form or by any means with acknowledgement of the original source. These permissions are granted for free by Elsevier for as long as the COVID-19 resource centre remains active.
spellingShingle Letter to the Editor
Prokopez, Cintia R.
Farinola, Romina
Vallejos, Miguel
Lopredo, Lorena S.
Sfriso, Luciano E.
Chiapella, Luciana C.
Arce, Claudio
Corral, Ricardo M.
Cuesta, Manuel J.
Alomo, Martín
Olanzapine, risperidone and quetiapine: Do these atypical antipsychotics have a protective effect for SARS-CoV-2?
title Olanzapine, risperidone and quetiapine: Do these atypical antipsychotics have a protective effect for SARS-CoV-2?
title_full Olanzapine, risperidone and quetiapine: Do these atypical antipsychotics have a protective effect for SARS-CoV-2?
title_fullStr Olanzapine, risperidone and quetiapine: Do these atypical antipsychotics have a protective effect for SARS-CoV-2?
title_full_unstemmed Olanzapine, risperidone and quetiapine: Do these atypical antipsychotics have a protective effect for SARS-CoV-2?
title_short Olanzapine, risperidone and quetiapine: Do these atypical antipsychotics have a protective effect for SARS-CoV-2?
title_sort olanzapine, risperidone and quetiapine: do these atypical antipsychotics have a protective effect for sars-cov-2?
topic Letter to the Editor
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8784573/
https://www.ncbi.nlm.nih.gov/pubmed/35123336
http://dx.doi.org/10.1016/j.schres.2022.01.035
work_keys_str_mv AT prokopezcintiar olanzapinerisperidoneandquetiapinedotheseatypicalantipsychoticshaveaprotectiveeffectforsarscov2
AT farinolaromina olanzapinerisperidoneandquetiapinedotheseatypicalantipsychoticshaveaprotectiveeffectforsarscov2
AT vallejosmiguel olanzapinerisperidoneandquetiapinedotheseatypicalantipsychoticshaveaprotectiveeffectforsarscov2
AT lopredolorenas olanzapinerisperidoneandquetiapinedotheseatypicalantipsychoticshaveaprotectiveeffectforsarscov2
AT sfrisolucianoe olanzapinerisperidoneandquetiapinedotheseatypicalantipsychoticshaveaprotectiveeffectforsarscov2
AT chiapellalucianac olanzapinerisperidoneandquetiapinedotheseatypicalantipsychoticshaveaprotectiveeffectforsarscov2
AT arceclaudio olanzapinerisperidoneandquetiapinedotheseatypicalantipsychoticshaveaprotectiveeffectforsarscov2
AT corralricardom olanzapinerisperidoneandquetiapinedotheseatypicalantipsychoticshaveaprotectiveeffectforsarscov2
AT cuestamanuelj olanzapinerisperidoneandquetiapinedotheseatypicalantipsychoticshaveaprotectiveeffectforsarscov2
AT alomomartin olanzapinerisperidoneandquetiapinedotheseatypicalantipsychoticshaveaprotectiveeffectforsarscov2